Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Buyer is responsible for lawful handling, storage, and use.
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Look for liposomal formats that ensure the nutrients reach your cells
AOD-9604 - Common Uses: Fat loss
4.2 Extracellular matrix remodeling ECM plays an important role in breast cancer pathogenesis and is remodeled by both cancer and stromal cells, particularly by cancer-associated fibroblasts (CAFs)
CL Answer Do any supplements help with fatty liver disease
US$ 26.96
US$ 25.27
US$ 24.12
